Mesoblast
MESO
17 hedge funds and large institutions have $10.7M invested in Mesoblast in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
13% more funds holding
Funds holding: 15 → 17 (+2)
4% more capital invested
Capital invested by funds: $10.3M → $10.7M (+$405K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Penbrook Management
New York
|
+$146K |
| 2 |
Jane Street
New York
|
+$47.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.6K |
| 4 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
+$9.73K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$4.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$535K |
| 2 |
Millennium Management
New York
|
-$77K |
| 3 |
PCMI
Princeton Capital Management Inc
Princeton,
New Jersey
|
-$57.8K |
| 4 |
MMA
Miracle Mile Advisors
Los Angeles,
California
|
-$41K |
MESO Hedge Fund Activity: Q3 2016 in Review
17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2016, worth a combined $10.7M — up 4% from $10.3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MESO positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Penbrook Management, opening a new position worth an estimated $146K. The largest seller was Credit Suisse, exiting entirely with an estimated $535K sold.
- 17 institutional investors held Mesoblast (MESO) as of Q3 2016, up from 15 in Q2 2016.
- Funds reported $10.7M of Mesoblast stock for Q3 2016, up 4% quarter-over-quarter.
- 5 funds opened new Mesoblast positions in Q3 2016 and 3 closed out, a net change of +2 holders.
- The largest Mesoblast buyer in Q3 2016 was Penbrook Management, an estimated $146K added.
- The largest Mesoblast seller in Q3 2016 was Credit Suisse, an estimated $535K sold.
Based on aggregated 13F filings for Q3 2016.